White & Case advises placing agents on Egetis Therapeutics’ directed share issue

Global law firm White & Case LLP has advised Bryan, Garnier & Co as sole global coordinator and, together with Handelsbanken Capital Markets, as joint bookrunners on the SEK 300 million directed share issue by Egetis Therapeutics AB (publ).Egetis Therapeutics is a pharmaceutical company focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment. The company is listed on the Nasdaq Stockholm main market. The White & Case team which advised on the transaction was led by partner